MCM2 and invasive breast carcinoma: In the same line, in our study, the MCM2 and SKP2 downregulation upon [C16Pyr][Amp] treatment suggests a role of this IL in DNA replication and cell cycle rate reduction in both BrCa and PCa cell lines.